[go: up one dir, main page]

WO2006067600A3 - Formulations a base d'herbe utilisees sous forme de pastille contre la toux - Google Patents

Formulations a base d'herbe utilisees sous forme de pastille contre la toux Download PDF

Info

Publication number
WO2006067600A3
WO2006067600A3 PCT/IB2005/003860 IB2005003860W WO2006067600A3 WO 2006067600 A3 WO2006067600 A3 WO 2006067600A3 IB 2005003860 W IB2005003860 W IB 2005003860W WO 2006067600 A3 WO2006067600 A3 WO 2006067600A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal formulations
formulations
polyherbal
cough lozenge
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/003860
Other languages
English (en)
Other versions
WO2006067600A2 (fr
Inventor
Chandra Kant Katiyar
Aravind Padiyar
Rahul Singh
Roopak Kumar
Anil Kanaujia
Navin Kumar Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2006067600A2 publication Critical patent/WO2006067600A2/fr
Publication of WO2006067600A3 publication Critical patent/WO2006067600A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des formulations pharmaceutiques à base de plusieurs herbes utilisées sous la forme de pastilles. Ces formulations pharmaceutiques se sont révélées être efficaces dans le traitement et la surveillance des toux et des angines. L'invention concerne également des procédés de préparation, de détection et d'analyse quantitative de substances phytochimiques individuelles utilisées dans ces formulations à base de plusieurs herbes.
PCT/IB2005/003860 2004-12-23 2005-12-22 Formulations a base d'herbe utilisees sous forme de pastille contre la toux Ceased WO2006067600A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2550DE2004 2004-12-23
IN2550/DEL/2004 2004-12-23

Publications (2)

Publication Number Publication Date
WO2006067600A2 WO2006067600A2 (fr) 2006-06-29
WO2006067600A3 true WO2006067600A3 (fr) 2006-08-24

Family

ID=36182116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003860 Ceased WO2006067600A2 (fr) 2004-12-23 2005-12-22 Formulations a base d'herbe utilisees sous forme de pastille contre la toux

Country Status (1)

Country Link
WO (1) WO2006067600A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017059088A1 (fr) * 2015-09-30 2017-04-06 George Edward Hoag Formulations analgésiques topiques pour soulager la douleur, leur fabrication et leurs procédés d'utilisation
CN108760947A (zh) * 2018-09-05 2018-11-06 翟纹静 三重四级杆气质联用检测水产品中多种麻醉剂的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US4980169A (en) * 1990-05-03 1990-12-25 Warner-Lambert Company Flavor enhancing and increasing efficacy of cough drops
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US4980169A (en) * 1990-05-03 1990-12-25 Warner-Lambert Company Flavor enhancing and increasing efficacy of cough drops
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"European Pharmacopoeia 4th Edition", 20 September 2001, EDQM COUNCIL OF EUROPE, STRASSBOURG, FRANCE, XP002382613 *
"European Pharmacopoeia 4th Edition", 20 September 2001, EDQM COUNCIL OF EUROPE, STRASSBOURG, FRANCE, XP002382614 *
ANONYMOUS: "Herbal/Ayurvedic", INTERNET ARTICLE, 31 October 2004 (2004-10-31), XP002382608, Retrieved from the Internet <URL:http://web.archive.org/web/20041031082625/http://www.acgil.com/archive/percos/other_products/branded_herbal001.htm> [retrieved on 20060524] *
ANONYMOUS: "Olbas Pastilles Throat Lozenges", INTERNET ARTICLE, 7 September 2003 (2003-09-07), XP002382855, Retrieved from the Internet <URL:http://web.archive.org/web/20030907164825/http://www.veganessentials.com/catalog/olbas-pastilles-throat-lozenges.htm> [retrieved on 20060524] *
SRIVASTAVA, S., VERMA, R.K., GUPTA, M.M., SINGH, S.C., AND KUMAR, S.: "HPLC determination of vasicine and vasicinone in Adhatoda vasica with photo diode array detection", JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, vol. 24, no. 2, 2001, pages 153 - 159, XP008064712 *

Also Published As

Publication number Publication date
WO2006067600A2 (fr) 2006-06-29

Similar Documents

Publication Publication Date Title
WO2007070052A3 (fr) Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l&#39;oxalate
WO2006107745A3 (fr) Composition pour le traitement de la menopause
WO2006099579A3 (fr) Compositions et procedes d&#39;amplification et d&#39;analyse cloniques de polynucleotides
WO2010009342A3 (fr) Inhibiteurs de tyrosine kinase de bruton pour le traitement de tumeurs solides
WO2006130436A3 (fr) Evenement de soja mon89788 et procedes de detection de celui-ci
NO20074753L (no) A pharmaceutical composition for treating depression and method for preparation thereof
WO2005086937A3 (fr) Procedes et compositions permettant la monoamine oxydase et la catechol-l-methyltransferase
BRPI0718586A2 (pt) Composto, processo para a sua preparação, composição farmacêutica contendo o mesmo, usos deste e método de tratamento ou prevenção de doenças
WO2008013966A3 (fr) Utilisation de 8-quinolinol et de ses analogues pour cibler des cellules souches cancéreuses
WO2006009765A3 (fr) Procedes d&#39;identification et d&#39;utilisation de composes adaptes au traitement de cellules cancereuses resistantes aux medicaments
WO2006076003A3 (fr) Souches virales de vaccine
WO2007059008A3 (fr) Indenoisoquinolines n-substituees et leur synthese
WO2007134350A8 (fr) Utilisation d&#39;un anticorps
WO2010041252A3 (fr) Utilisation d&#39;un extrait d&#39;écorce de cannelle dans le traitement de maladies associées à l&#39;amyloïde
WO2008155390A3 (fr) Utilisation d&#39;inhibiteurs de sirtuines et/ou de l&#39;ampk dans la préparation d&#39;un médicament destiné au traitement des maladies à polyalanine
WO2005089310A3 (fr) Test pour identifier la mauvaise haleine
WO2006067600A3 (fr) Formulations a base d&#39;herbe utilisees sous forme de pastille contre la toux
WO2007028151A3 (fr) Dispositifs chirurgicaux et methodes associees
WO2005049058A8 (fr) Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l&#39;aspirine
EP1845928A4 (fr) Extrait de melange d&#39;herbes de radix notoginseng, de radix rehmanniae praeparata et de cortex acanthopanacis et composition comprenant celui-ci servant a prevenir et a traiter l&#39;arthrite
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
SI1819320T1 (sl) Oralno disperzibilen farmacevtski sestavek in postopek za njegovo pripravo
BR112012009369A2 (pt) extrato vegetal padronizado, processo para preparação de extrato de plantas do gênero sclerolobium, composição cosmética, composição farmacêutica e uso do referido extrato
DK1906921T3 (da) Klar farmaceutisk, vandig mikroemulsion omfattende propofol og fremgangsmåde til fremstilling
WO2006134609A3 (fr) Nouvel agent anticancereux, procedes de preparation et compositions pharmaceutiques correspondantes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05824913

Country of ref document: EP

Kind code of ref document: A2